Abstract
Background: Transdermal patches are convenient to use, especially in Rotkreuz ZG Rotkreuz ZG patients with Alzheimer’s disease (AD)-associated dementia. However, various identified risks of errors in administering the patches cannot be disregarded. Patient Reminder Cards (PRCs, included a Medication record sheet [MRS]) have been recently introduced as a risk minimisation tool to prevent incorrect patch use (IU).
Objectives: This study aimed to assess the effectiveness of PRCs to prevent IU and to investigate the dose titration pattern of rivastigmine patches in a real-world setting.
Methods: This multinational, observational, 11-month study included patients with AD currently using rivastigmine patches (4.6 mg/day, 9.5 mg/day, 13.3 mg/day) accompanied by a caregiver. Study outcomes were IU, including multiple patch use (MPU), incorrect patch placement, other IUs, perceived usefulness of the PRCs, and titration patterns of the patches.
Results: Of the total 614 patients included, most were aged ≥ 65 years and had mild-to-moderate AD. Before and during the study, 27.7% and 18.0% of patients reported IU, respectively. Most patients used MRS, and 73.5% rated it ‘helpful’ and reported lower rates of IU than those who reported it ‘not helpful’ (13.9%-16.5% vs. 20.2%). Overall, 141 patients had dose titrations, with 75.8% being up-titrated from 4.6 mg/day to 9.5 mg/day after a mean duration of 58 days. Safety findings were consistent with the established profile for the rivastigmine patch.
Conclusion: PRC was effective as a risk minimisation tool in limiting the inappropriate use of rivastigmine patches. The majority of patients requiring dose-change were up-titrated to 9.5 mg/day patches.
Keywords: Rivastigmine patch, inappropriate medication use, multiple patch use, Alzheimer’s dementia, neurodegenerative conditions, corticobasal syndrome.
[http://dx.doi.org/10.1111/j.1468-1331.2012.03784.x] [PMID: 22891773]
[http://dx.doi.org/10.1136/jnnp.2005.082867] [PMID: 16291918]
[http://dx.doi.org/10.1093/geront/gnx103]
[http://dx.doi.org/10.1155/2012/728983] [PMID: 22216416]
[http://dx.doi.org/10.1093/ageing/afu143] [PMID: 25341676]
[http://dx.doi.org/10.1111/j.1471-4159.2009.06490.x] [PMID: 19912467]
[http://dx.doi.org/10.1371/journal.pone.0021954] [PMID: 21799757]
[http://dx.doi.org/10.2174/1567205054367838] [PMID: 15974896]
[http://dx.doi.org/10.1177/2042098617750555] [PMID: 29492246]
[http://dx.doi.org/10.1002/gps.1806] [PMID: 17407176]
[http://dx.doi.org/10.1586/14737175.2015.1068120] [PMID: 26289489]
[PMID: 22536070]
[http://dx.doi.org/10.1159/000501364] [PMID: 31572426]
[http://dx.doi.org/10.1002/gps.2534] [PMID: 21312297]
[http://dx.doi.org/10.1159/000338228] [PMID: 23139687]
[http://dx.doi.org/10.1089/jpm.2017.0578] [PMID: 29473770]
[http://dx.doi.org/10.1186/2050-6511-15-31] [PMID: 24912424]
[http://dx.doi.org/10.1517/14740338.2014.926888] [PMID: 24921682]
[http://dx.doi.org/10.1371/journal.pone.0144337] [PMID: 26642212]
[http://dx.doi.org/10.2174/157488612800492717] [PMID: 22663954]
[http://dx.doi.org/10.1080/15563650.2017.1329536] [PMID: 28594244]
[http://dx.doi.org/10.1097/EDE.0b013e3181577511] [PMID: 18049195]
[http://dx.doi.org/10.1016/j.nrl.2016.02.016] [PMID: 27130306]
[PMID: 26393402]